Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What’s New? and Energy and Macronutrient Metabolism (EMM) GEM Forum

Chair(s)

• 

  Christos Katsanos, PhD (he/him/his)

  Associate Professor
  Arizona State University
  Phoenix, Arizona, United States

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Speaker(s)

• 

  Monica Agarwal, MD, MEHP, PNS, FACE

  Professor of Medicine and the Director, UAB Obesity Medicine Fellowship Program
  University of Alabama at Birmingham
  Birmingham, Alabama, United States

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
• 

  Jaime Almandoz, MD, MBA, MRCPI, FTOS (he/him/his)

  Medical Director, Weight Wellness Program; Associate Professor of Internal Medicine; Division of Endocrinology
  UT Southwestern Medical Center
  Dallas, Texas, United States

  Disclosure(s): ABBVIE: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Eli Lilly: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Nestlé: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Novo Nordisk: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  WAVE LIFE SCIENCES: Advisory Committee/Board Member (Terminated); Consultant (Terminated)
• 

  Jamy Ard, MD (he/him/his)

  Professor, Epidemiology & Prevention
  Wake Forest School of Medicine, Department of Epidemiology and Prevention
  Winston Salem, North Carolina, United States

  Disclosure(s): Amgen: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Boehringer Ingelheim: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Epitomee: Grant/Research Support (Terminated)
  Nestle Healthcare Nutrition: Consultant (Ongoing)
  Novo Nordisk: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Regeneron: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Weight Watchers: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Zealand Pharma: Consultant (Ongoing)

Recently developed anti-obesity medications have revolutionized obesity treatment with significant weight loss outcomes. This engaging session explores the vital nutritional considerations for individuals on these medications. Attendees will gain insights into the evaluation, management, and follow-up strategies that optimize nutritional care for patients with obesity, ensuring lasting success throughout their weight loss therapy.

This session will also include a discussion of Nutritional Priorities to Support GLP-1 Therapy for Weight Loss: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.

Presentations:

• 2:00 PM – 2:05 PM ET

  Welcome and Introductions - Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What’s New? and Energy and Macronutrient Metabolism (EMM) GEM Forum
  

  Chair: Christos S. Katsanos, PhD (he/him/his) – Arizona State University
• 2:05 PM – 2:50 PM ET

  Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What’s New?
  

  Speaker: Jaime Almandoz, MD, MBA, MRCPI, FTOS (he/him/his) – UT Southwestern Medical Center

  Speaker: Jamy D. Ard, MD (he/him/his) – Wake Forest School of Medicine, Department of Epidemiology and Prevention
• 2:50 PM – 3:05 PM ET

  Panel Discussion / Questions and Answers - Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What’s New?
  

  Chair: Christos S. Katsanos, PhD (he/him/his) – Arizona State University

  Speaker: Jaime Almandoz, MD, MBA, MRCPI, FTOS (he/him/his) – UT Southwestern Medical Center

  Speaker: Jamy D. Ard, MD (he/him/his) – Wake Forest School of Medicine, Department of Epidemiology and Prevention
• 3:05 PM – 3:20 PM ET

  Nutritional Priorities to Support GLP-1 Therapy for Weight Loss: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
  

  Speaker: Monica Agarwal, MD, MEHP, PNS, FACE – University of Alabama at Birmingham
• 3:20 PM – 3:30 PM ET

  Questions and Answers - Nutritional Priorities to Support GLP-1 Therapy for Weight Loss: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
  

  Speaker: Monica Agarwal, MD, MEHP, PNS, FACE – University of Alabama at Birmingham